Natera Inc Quick Ratio (NTRA) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Natera Inc   (NASDAQ: NTRA)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Natera Inc 's Quick Ratio

NTRA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




Within Medical Laboratories industry 17 other companies have achieved higher Quick Ratio than Natera Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 0 to 1273.

Explain Quick Ratio?
How much Cash & cash equivalents NTRA´s has?
What are NTRA´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/NTRA/financial-strength
https://api.csimarket.com/api/v1/companies/NTRA/fundamentals
https://api.csimarket.com/api/v1/companies/NTRA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
NTRA Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 38.66 %
Y / Y Cash & cash equivalent Change -
Quick Ratio MRQ -
NTRA's Total Ranking # 1273
Seq. Current Liabilities Change 10.79 %
Seq. Cash & cash equivalent Change -



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Laboratories Industry # 18
Healthcare Sector # 505
Overall Market # 1273


Quick Ratio Statistics
High Average Low
7.12 2.23 0
(Sep 30 2015)   (Sep 30 2025)




Financial Statements
Natera Inc 's Current Liabilities $ 613 Millions Visit NTRA's Balance sheet
Natera Inc 's Cash & cash equivalent $ 0 Millions Visit NTRA's Balance sheet
Source of NTRA's Sales Visit NTRA's Sales by Geography


Cumulative Natera Inc 's Quick Ratio

NTRA's Quick Ratio for the trailling 12 Months

NTRA Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 39.16 %
Y / Y Cash & cash equivalent TTM Growth 1798.4 %
Quick Ratio TTM 0.5
Total Ranking TTM #
Seq. Current Liabilities TTM Growth 8.57 %
Seq. Cash & cash equivalent TTM Growth -0.09 %


On the trailing twelve months basis Due to increase in Current Liabilities in the Q3 2026 to $612.90 millions, cumulative Quick Ratio decreased to 0.5 below the Natera Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 17 other companies have achieved higher Quick Ratio than Natera Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3217 to 4066.

Explain Quick Ratio?
How much Cash & cash equivalents NTRA´s has?
What are NTRA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 18
Healthcare Sector # 505
Within the Market # 1273


trailing twelve months Quick Ratio Statistics
High Average Low
7.12 2.23 0
(Sep 30 2015)   (Sep 30 2025)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Laboratories Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities

Date modified: 2026-11-06T13:00:59+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.